Is it safe to readminister tumor necrosis factor α antagonists following tuberculosis flare?

Arthritis and Rheumatism

Volumn 58, Issue 1, 2008, Pages 327-328

  Aslanidis, Spyros ^a   Pyrpasopoulou, Athina ^a   Douma, Stella ^a   Petidis, Konstantinos ^a  

^a Aristotle University of Thessaloniki   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETHAMBUTOL; INFLIXIMAB; ISONIAZID; METHOTREXATE; RIFAMPICIN; STREPTOMYCIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; FEMALE; HUMAN; INFECTION SENSITIVITY; LOW DRUG DOSE; LUNG BIOPSY; LYMPH NODE BIOPSY; MALE; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SCREENING TEST; SPUTUM CULTURE; THORAX RADIOGRAPHY;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38149011457     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23210     Document Type: Article

References (8)

1. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002;46:328-46.
2. Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med 2004;350:2167-79.
3. Askling J, Fored CM, Brandt L, Baecklund E, Bertillson L, Coster L, et al. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 2005;52:1986-92.
4. Sichletidis L, Settas L, Spyratos D, Chloros D, Patakas D. Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis. Int J Tuberc Lung Dis 2006;10:1127-32.
5. Saunders BM, Britton WJ. Life and death in the granuloma: immunopathology of tuberculosis. Immunol Cell Biol 2007;85:103-11.
6. Iliopoulos A, Psathakis K, Aslanidis S, Skagias L, Sfikakis PP. Tuberculosis and granuloma formation in patients receiving anti-TNF therapy. Int J Tuberc Lung Dis 2006;10:588-90.
7. Wallis RS. Reconsidering adjuvant immunotherapy for tuberculosis. Clin Infect Dis 2005;41:201-8.
8. Molenaar ET, Bultink IE, Dijkmans BA, Lems WF. Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al [letter]. Arthritis Rheum 2005;52:1334-6.